✦ LIBER ✦

Introduction to economic modeling for clinical rheumatologists: application to biologic agents in rheumatoid arthritis

✍ Scribed by Carlo A. Marra; Nick Bansback; Aslam H. Anis; Kamran Shojania

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness modeling of abatacept

✍ Anthony Russell; Ariel Beresniak; Louis Bessette; Boulos Haraoui; Proton Rahman; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 183 KB

PMS75 Explanatory Factors for the Rheuma

✍ P.A. Laires; F. Exposto; P. Barosa; B. Hormigos; A.P. Martins 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMS37 Economic Evaluation Model of Biolo

✍ X. Wang; N. Bansback; A. Anis; A.D. Joshi; S. Rao; M. Wolff; M. Cifaldi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Clinical evaluation of tocilizumab for p

✍ Yasuharu Nakashima; Masakazu Kondo; Hiroshi Harada; Takahiko Horiuchi; Takashi I 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 348 KB

PMS71 INDIRECT TREATMENT COMPARISON TO C

✍ M Lebmeier; L Pericleous; P Guyot; H Baig; R Christensen; G Bergman; PC Taylor; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PMS40 COST-EFFECTIVENESS SIMULATION MODE

✍ Beresniak, A; Baerwald, C; Zeidler, H; Gromnica-lhle, E; Kruger, K; Neubauer, AS 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB